Tri Locum Partners LP Quant / Systematic

Location: New York, NY

CIK: 0001826434 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value: $435M (100.0% shares, 0.0% debt)

Holdings (18)

JNJ JOHNSON & JOHNSON 12.9%
Value $56.15M Shares 302,831 Est. Cost $169.51 Unrealized 0.0%
UTHR UNITED THERAPEUTICS CORP DEL 11.8%
Value $51.22M Shares 122,187 Est. Cost $336.31 Unrealized 0.0%
MRK MERCK & CO INC 8.6%
Value $37.51M Shares 446,874 Est. Cost $81.01 Unrealized 0.0%
AXSM AXSOME THERAPEUTICS INC 8.2%
Value $35.48M Shares 292,137 Est. Cost $101.43 Unrealized +11.1%
ASND ASCENDIS PHARMA A/S 8.0%
Value $34.76M Shares 174,829 Est. Cost $173.58 Unrealized
VERA VERA THERAPEUTICS INC 8.0%
Value $34.59M Shares 1,190,207 Est. Cost $24.12 Unrealized -4.1%
ARGX ARGENX SE 7.4%
Value $32.02M Shares 43,411 Est. Cost $507.27 Unrealized
MDGL MADRIGAL PHARMACEUTICALS INC 7.1%
Value $31.05M Shares 67,706 Est. Cost $267.97 Unrealized +39.2%
SLNO SOLENO THERAPEUTICS INC 7.0%
Value $30.46M Shares 450,585 Est. Cost $60.96 Unrealized +21.6%
ABBV ABBVIE INC 4.8%
Value $20.75M Shares 89,621 Est. Cost $189.97 Unrealized +6.3%
KRRO KORRO BIO INC 3.7%
Value $16.18M Shares 337,764 Est. Cost $33.68 Unrealized -34.1%
XENE XENON PHARMACEUTICALS INC 3.4%
Value $14.7M Shares 366,102 Est. Cost $35.22 Unrealized 0.0%
AVADEL PHARMACEUTICALS PLC 2.5%
Value $11.07M Shares 724,859 Est. Cost $8.85 Unrealized
STVN STEVANATO GROUP S P A 2.0%
Value $8.572M Shares 332,912 Est. Cost $24.68 Unrealized 0.0%
DNTH DIANTHUS THERAPEUTICS INC 1.7%
Value $7.196M Shares 182,867 Est. Cost $25.56 Unrealized 0.0%
TARS TARSUS PHARMACEUTICALS INC 1.6%
Value $7.088M Shares 119,260 Est. Cost $45.00 Unrealized +9.4%
PRAX PRAXIS PRECISION MEDICINES I 0.9%
Value $4.027M Shares 75,986 Est. Cost $50.40 Unrealized -3.8%
BHVN BIOHAVEN LTD 0.5%
Value $2.239M Shares 149,179 Est. Cost $17.82 Unrealized -18.3%